Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950170-25-021393
Filing Date
2025-02-14
Accepted
2025-02-14 17:00:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 13157
  Complete submission text file 0000950170-25-021393.txt   14873
Mailing Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210 (646) 350-0702
Akari Therapeutics Plc (Subject) CIK: 0001541157 (see all company filings)

EIN.: 981034922 | State of Incorp.: X0
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-87614 | Film No.: 25630508
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 71 SHEPHERDS HILL LONDON X0 N6 5RE
Business Address
Prudo-Chlebosz Raymond (Filed by) CIK: 0001653262 (see all company filings)

Type: SCHEDULE 13D/A